DEF 14AThe Ballot
Travere Therapeutics, Inc. files DEF 14A
Filed Mar 27, 2024 · 2y ago · Accession 0001438533-24-000012
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Travere Therapeutics, Inc.
- Ticker
- TVTX
- CIK
- 1438533
- Form type
- DEF 14A
- Filing date
- Mar 27, 2024
- Report date
- May 8, 2024
- Document
- tvtx-20240327.htm
- Size
- 2.4 MB